Yun‐Song Yang

机构：Fudan University Shanghai Cancer Center · ORCID：0000-0001-8067-9567

发表论文 37 篇 · 总被引 1354 次 · h-index 13

代表论文

• Comprehensive metabolomics expands precision medicine for triple-negative breast cancer (2022 · Cell Research · 被引 338)
• Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial (2024 · The Lancet Oncology · 被引 71)
• Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression (2022 · Proceedings of the National Academy of Sciences · 被引 37)
• Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer (2023 · Cancer Research · 被引 29)
• Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer (2025 · Science Translational Medicine · 被引 24)
• HSP90 N‐terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2‐driven breast cancer progression (2022 · Clinical and Translational Medicine · 被引 14)